Holen Sie sich die Stockscreener-App
5.32
1.12%
-0.06
Handel nachbörslich:
5.32
Schlusskurs vom Vortag:
$5.38
Offen:
$5.39
24-Stunden-Volumen:
254.54K
Relative Volume:
1.37
Marktkapitalisierung:
$202.36M
Einnahmen:
$239.40M
Nettoeinkommen (Verlust:
$104.44M
KGV:
1.7973
EPS:
2.96
Netto-Cashflow:
$-18.50M
1W Leistung:
-6.34%
1M Leistung:
-8.28%
6M Leistung:
-53.05%
1J Leistung:
-66.01%
1-Tages-Spanne:
$5.26
$5.6556
1-Wochen-Bereich:
$5.26
$5.76
52-Wochen-Spanne:
$4.93
$21.79
Entrada Therapeutics Inc Stock (TRDA) Company Profile
Firmenname
Entrada Therapeutics Inc
Sektor
Branche
Telefon
857-305-1825
Adresse
ONE DESIGN CENTER PLACE, BOSTON
Vergleichen Sie TRDA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TRDA
Entrada Therapeutics Inc
|
5.32 | 204.64M | 239.40M | 104.44M | -18.50M | 2.96 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.62 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.80 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
447.43 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
722.01 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
336.26 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Entrada Therapeutics Inc Stock (TRDA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-06 | Eingeleitet | ROTH MKM | Buy |
| 2024-01-05 | Eingeleitet | Oppenheimer | Outperform |
| 2023-04-03 | Eingeleitet | H.C. Wainwright | Buy |
Entrada Therapeutics Inc Aktie (TRDA) Neueste Nachrichten
What MACD and RSI say about Entrada Therapeutics Inc.2025 Top Decliners & Community Verified Trade Alerts - Newser
Using R and stats models for Entrada Therapeutics Inc. forecastingIPO Watch & Weekly High Return Opportunities - Newser
Detecting support and resistance levels for Entrada Therapeutics Inc.July 2025 EndofMonth & Reliable Volume Spike Alerts - Newser
Institutional scanner results for Entrada Therapeutics Inc.Market Activity Recap & Entry Point Confirmation Alerts - Newser
Candlestick signals on Entrada Therapeutics Inc. stock todayGap Up & Free Reliable Trade Execution Plans - Newser
Is Entrada Therapeutics Inc. stock ready for a breakoutJuly 2025 Recap & Verified Swing Trading Watchlist - Newser
What MACD and RSI say about Entrada Therapeutics IncJuly 2025 Reactions & Real-Time Stock Movement Alerts - Newser
Real time social sentiment graph for Entrada Therapeutics Inc.Quarterly Portfolio Report & Trade Opportunity Analysis - Newser
How to recover losses in Entrada Therapeutics Inc. stockJuly 2025 Review & Safe Capital Investment Plans - Newser
Entrada Therapeutics Inc. stock trend outlook and recovery path2025 Trade Ideas & Weekly Watchlist for Hot Stocks - Newser
Automated trading signals detected on Entrada Therapeutics Inc.Trade Performance Summary & Weekly Top Stock Performers List - Newser
Momentum divergence signals in Entrada Therapeutics Inc. chartQuarterly Market Review & Weekly Top Gainers Trade List - Newser
Strategic Equity Incentives and Talent Retention in High-Growth Biotech - AInvest
Entrada Therapeutics announces inducement grants under Nasdaq listing rule 5635(c)(4) - MarketScreener
93,210 Shares: Entrada Therapeutics Issues Major Equity Compensation Package to New Hires at $5.47 - Stock Titan
Can a trend reversal in Entrada Therapeutics Inc. lead to recoveryQuarterly Profit Review & Real-Time Buy Signal Alerts - Newser
What earnings revisions data tells us about Entrada Therapeutics Inc.Earnings Risk Report & Advanced Technical Signal Analysis - Newser
Is Entrada Therapeutics Inc. subject to activist investor interestWall Street Watch & Weekly High Conviction Trade Ideas - khodrobank.com
Published on: 2025-09-02 06:10:46 - Newser
Can machine learning forecast Entrada Therapeutics Inc. recoveryInflation Watch & Weekly Stock Performance Updates - Newser
Will Entrada Therapeutics Inc. benefit from rising consumer demandEarnings Risk Report & Growth Focused Stock Pick Reports - خودرو بانک
Exit strategy if you’re trapped in Entrada Therapeutics Inc.Insider Selling & Accurate Buy Signal Alerts - Newser
Is Entrada Therapeutics Inc. currently under institutional pressureJuly 2025 Reactions & Smart Allocation Stock Tips - khodrobank.com
Is a relief rally coming for Entrada Therapeutics Inc. holdersGap Down & Long-Term Investment Growth Plans - Newser
Can Entrada Therapeutics Inc. disrupt its industryEarnings Recap Report & Growth-Oriented Investment Plans - khodrobank.com
Is Entrada Therapeutics Inc. showing insider buying2025 Earnings Surprises & Daily Stock Momentum Reports - khodrobank.com
Will Entrada Therapeutics Inc. benefit from rate cutsM&A Rumor & High Win Rate Trade Alerts - khodrobank.com
Published on: 2025-09-01 09:55:24 - Newser
Is Entrada Therapeutics Inc. stock a good dividend stock2025 Trade Ideas & High Conviction Buy Zone Picks - khodrobank.com
Published on: 2025-09-01 11:33:07 - beatles.ru
Entrada Therapeutics Inc. Could See a Relief Rally From SupportJuly 2025 Institutional & Daily Entry Point Alerts - beatles.ru
Trend analysis for Entrada Therapeutics Inc. this weekJuly 2025 Snapshot & Reliable Intraday Trade Alerts - Newser
Regression analysis insights on Entrada Therapeutics Inc. performanceJuly 2025 Fed Impact & Verified Swing Trading Watchlist - Newser
Entrada Therapeutics (TRDA) Soars 5.6%: Is Further Upside Left in the Stock? - MSN
Applying Elliott Wave Theory to Entrada Therapeutics Inc.Weekly Risk Summary & Precise Swing Trade Alerts - Newser
Sector Rotation Brings Entrada Therapeutics Inc. Into Focus getLinesFromResByArray error: size == 0 - thegnnews.com
Is Entrada Therapeutics Inc. meeting your algorithmic filter criteriaSwing Trade & Accurate Intraday Trading Signals - Newser
Combining price and volume data for Entrada Therapeutics Inc.2025 Valuation Update & Risk Controlled Stock Pick Alerts - Newser
Finanzdaten der Entrada Therapeutics Inc-Aktie (TRDA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.14%
1.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):